Vaccines Global Market Opportunities And Strategies To 2031

Description

“Vaccines Global Market Opportunities And Strategies To 2031 ” from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global vaccines market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Where is the largest and fastest-growing market for vaccines? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? “The vaccines market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider vaccines market; and compares it with other markets.

The report covers the following chapters:

Introduction and Market Characteristics: Brief introduction to the segmentations covered in the market, definitions and explanations about vaccines market.

Key Trends: Highlights the major trends shaping the global vaccines market. This section also highlights likely future developments in the market.

Global Market Size and Growth: Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional Analysis: Historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region.

Market Segmentation: Contains the market values (2016-2031) and analysis for for segment by type, segmentation by technology, segmentation by route of administration, segmentation by valance and segmentation by distribution channel in the market.

Regional Market Size and Growth: Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.

Competitive Landscape: Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.

Pipeline Analysis: Briefs on the pipeline analysis of vaccines from the major players in the market.

Key Mergers and Acquisitions: Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.

Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.

Conclusions And Recommendations - This section Includes recommendations for vaccines providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.

Appendix: This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

1) By Type: Anti-Infective Vaccines; Anti-Cancer Vaccines; Other Types

2) By Technology: Conjugate Vaccines; Inactivated And Subunit Vaccines; Live Attenuated Vaccines; Recombinant Vaccines; Toxoid Vaccines; Other Technologies

3) By Route Of Administration: Intramuscular (IM); Subcutaneous (SC); Oral; Other Route of Administration

4) By Valance: Monovalent; Multivalent

5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Institutional Sales

Companies Mentioned: Pfizer Inc.; Merck & Co., Inc.; GlaxoSmithKline plc; Sanofi S.A.; AstraZeneca

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; vaccines indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; vaccines market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s685

1.Executive Summary

2.Table Of Contents

3.List Of Figures

4.List Of Tables

5.Report Structure

6.Introduction And Market Characteristics

6.1.General Market Definition
6.2.Summary
6.3.Vaccines Market Definition And Segmentations
6.4.Market Segmentation By Type
- 6.4.1.Anti-Infective Vaccines
- 6.4.2.Anti-Cancer Vaccines
- 6.4.3.Other Types
6.5.Market Segmentation By Technology
- 6.5.1.Conjugate Vaccines
- 6.5.2.Inactivated And Subunit Vaccines
- 6.5.3.Live Attenuated Vaccines
- 6.5.4.Recombinant Vaccines
- 6.5.5.Toxoid Vaccines
- 6.5.6.Other Technologies
6.6.Market Segmentation By Route Of Administration
- 6.6.1.Intramuscular (IM)
- 6.6.2.Subcutaneous (SC)
- 6.6.3.Oral
- 6.6.4.Other Route of Administration
6.7.Market Segmentation By Valance
- 6.7.1.Monovalent
- 6.7.2.Multivalent
6.8.Market Segmentation By Distribution Channel
- 6.8.1.Hospital Pharmacies
- 6.8.2.Retail Pharmacies
- 6.8.3.Institutional Sales

7.Major Market Trends

7.1.Synthetic Biology In Vaccine Development
7.2.Development Of Combination Vaccines
7.3.Robust Research And Development
7.4.Increasing Demand For Conjugate Vaccines
7.5.Artificial Intelligence In Vaccine Development
7.6.mRNA Vaccines
7.7.Cancer Vaccines
7.8.Increasing Acquisitions And Partnerships

8.Global Market Size And Growth

8.1.Market Size
8.2.Historic Market Growth, 2016 - 2021, Value ($ Million)
- 8.2.1.Market Drivers 2016 - 2021
- 8.2.2.Market Restraints 2016 - 2021
8.3.Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
- 8.3.1.Market Drivers 2021 - 2026
- 8.3.2.Market Restraints 2021 - 2026

9.Global Vaccines Market Segmentation

9.1.Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.2.Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.3.Global Vaccines Market, Segmentation By Route Of Administration, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.4.Global Vaccines Market, Segmentation By Valence, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
9.5.Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

10.Vaccines Market, Regional and Country Analysis

10.1.Global Vaccines Market, By Region, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
10.2.Global Vaccines Market, By Country, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

11.Asia-Pacific Market

11.1.Summary
11.2.Market Overview
- 11.2.1.Region Information
- 11.2.2.Market Information
- 11.2.3.Background Information
- 11.2.4.Government Initiatives
- 11.2.5.Regulations
- 11.2.6.Regulatory Bodies
- 11.2.7.Major Associations
- 11.2.8.Taxes Levied
- 11.2.9.Corporate Tax Structure
- 11.2.10.Investments
- 11.2.11.Major Companies
11.3.Asia-Pacific Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.4.Asia-Pacific Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.5.Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.6.Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.7.Asia-Pacific Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.8.Asia-Pacific Vaccines Market: Country Analysis
11.9.China Market
11.10.Summary
11.11.Market Overview
- 11.11.1.Country Information
- 11.11.2.Market Information
- 11.11.3.Background Information
- 11.11.4.Government Initiatives
- 11.11.5.Regulations
- 11.11.6.Regulatory Bodies
- 11.11.7.Major Associations
- 11.11.8.Taxes Levied
- 11.11.9.Corporate Tax Structure
- 11.11.10.Investments
- 11.11.11.Major Companies
11.12.China Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.13.China Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.14.China Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.15.China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.16.China Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.17.India Market
11.18.India Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.19.India Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.20.India Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.21.India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.22.India Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.23.Japan Market
11.24.Japan Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.25. Japan Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.26. Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.27. Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.28. Japan Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.29. Australia Market
11.30. Australia Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.31. Australia Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.32. Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.33. Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.34. Australia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.37. Indonesia Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.38. Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.39. Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.40. Indonesia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
11.43. South Korea Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
11.44. South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.45. South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
11.46. South Korea Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

12. Western Europe Market

12.1. Summary
12.2. Market Overview
- 12.2.1. Region Information
- 12.2.2. Market Information
- 12.2.3. Background Information
- 12.2.4. Government Initiatives
- 12.2.5. Regulations
- 12.2.6. Regulatory Bodies
- 12.2.7. Major Associations
- 12.2.8. Taxes Levied
- 12.2.9. Corporate Tax Structure
- 12.2.10. Investments
- 12.2.11. Major Companies
12.3. Western Europe Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.4. Western Europe Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.5. Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.6. Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.7. Western Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.8. Western Europe Vaccines Market: Country Analysis
12.9. UK Market
12.10. UK Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.11. UK Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.12. UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.13. UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.14. UK Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.15. Germany Market
12.16. Germany Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.17. Germany Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.18. Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.19. Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.20. Germany Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.21. France Market
12.22. France Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
12.23. France Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
12.24. France Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.25. France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
12.26. France Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

13. Eastern Europe Market

13.1. Summary
13.2. Market Overview
- 13.2.1. Region Information
- 13.2.2. Market Information
- 13.2.3. Background Information
- 13.2.4. Government Initiatives
- 13.2.5. Regulations
- 13.2.6. Regulatory Bodies
- 13.2.7. Major Associations
- 13.2.8. Taxes Levied
- 13.2.9. Corporate Tax Structure
- 13.2.10. Investments
- 13.2.11. Major Companies
13.3. Eastern Europe Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.4. Eastern Europe Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.5. Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.6. Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.7. Eastern Europe Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.8. Eastern Europe Vaccines Market: Country Analysis
13.9. Russia Market
13.10. Russia Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
13.11. Russia Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
13.12. Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.13. Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
13.14. Russia Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

14. North America Market

14.1. Summary
14.2. Market Overview
- 14.2.1. Region Information
- 14.2.2. Market Information
- 14.2.3. Background Information
- 14.2.4. Government Initiatives
- 14.2.5. Regulations
- 14.2.6. Regulatory Bodies
- 14.2.7. Major Associations
- 14.2.8. Taxes Levied
- 14.2.9. Corporate Tax Structure
- 14.2.10. Investments
- 14.2.11. Major Companies
14.3. North America Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.4. North America Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.5. North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.6. North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.7. North America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.8. North America Vaccines Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
- 14.11.1. Country Information
- 14.11.2. Market Information
- 14.11.3. Background Information
- 14.11.4. Government Initiatives
- 14.11.5. Regulations
- 14.11.6. Regulatory Bodies
- 14.11.7. Major Associations
- 14.11.8. Taxes Levied
- 14.11.9. Corporate Tax Structure
- 14.11.10. Investments
- 14.11.11. Major Companies
14.12. USA Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
14.13. USA Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
14.14. USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.15. USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
14.16. USA Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

15. South America Market

15.1. Summary
15.2. Market Overview
- 15.2.1. Region Information
- 15.2.2. Market Information
- 15.2.3. Background Information
- 15.2.4. Government Initiatives
- 15.2.5. Regulations
- 15.2.6. Regulatory Bodies
- 15.2.7. Major Associations
- 15.2.8. Taxes Levied
- 15.2.9. Corporate Tax Structure
- 15.2.10. Investments
- 15.2.11. Major Companies
15.3. South America Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.4. South America Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.5. South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.6. South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.7. South America Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.8. South America Vaccines Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
15.11. Brazil Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
15.12. Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.13. Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
15.14. Brazil Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

16. Middle East Market

16.1. Summary
16.2. Market Overview
- 16.2.1. Region Information
- 16.2.2. Market Information
- 16.2.3. Background Information
- 16.2.4. Government Initiatives
- 16.2.5. Regulations
- 16.2.6. Regulatory Bodies
- 16.2.7. Major Associations
- 16.2.8. Taxes Levied
- 16.2.9. Corporate Tax Structure
- 16.2.10. Investments
- 16.2.11. Major Companies
16.3. Middle East Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
16.4. Middle East Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
16.5. Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.6. Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
16.7. Middle East Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

17. Africa Market

17.1. Summary
17.2. Market Overview
- 17.2.1. Region Information
- 17.2.2. Market Information
- 17.2.3. Background Information
- 17.2.4. Government Initiatives
- 17.2.5. Regulations
- 17.2.6. Regulatory Bodies
- 17.2.7. Major Associations
- 17.2.8. Taxes Levied
- 17.2.9. Corporate Tax Structure
- 17.2.10. Investments
- 17.2.11. Major Companies
17.3. Africa Vaccines Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
17.4. Africa Vaccines Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
17.5. Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.6. Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
17.7. Africa Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

18. Competitive Landscape and Company Profiles

19. Company Profiles

19.1. Pfizer Inc
- 19.1.1. Company Overview
- 19.1.2. Products And Services
- 19.1.3. Business Strategy
- 19.1.4. Financial Overview
19.2. Merck & Co., Inc
- 19.2.1. Company Overview
- 19.2.2. Products And Services
- 19.2.3. Business Strategy
- 19.2.4. Financial Overview
19.3. GlaxoSmithKline plc
- 19.3.1. Company Overview
- 19.3.2. Products And Services
- 19.3.3. Business Strategy
- 19.3.4. Financial Overview
19.4. Sanofi S.A
- 19.4.1. Company Overview
- 19.4.2. Products And Services
- 19.4.3. Business Strategy
- 19.4.4. Financial Overview
19.5. AstraZeneca plc
- 19.5.1. Company Overview
- 19.5.2. Products And Services
- 19.5.3. Business Strategy
- 19.5.4. Financial Overview

20. Pipeline Analysis

21. Key Mergers And Acquisitions

21.1. GSK plc Acquired Affinivax Inc
21.2. Ceva Sante Animale Acquired Artemis Technologies Inc.
21.3. Pfizer Inc. Acquired ReViral Ltd.
21.4. NEC OncoImmunity AS Acquired Vaximm AG's Neoantigen Vaccine Development Assets.
21.5. Sanofi S.A. To Acquire Origimm Biotechnology GmbH
21.6. Vaccitech plc Acquired Avidea Technologies, Inc.
21.7. Shanghai Fosun Pharmaceutical Co., Ltd. Acquired Chengdu Antejin Biotech Co. Ltd.
21.8. Sanofi S.A. Acquired Translate Bio, Inc.
21.9. Thermo Fisher Scientific Inc. Acquired Viral Vector Manufacturing Business from Novasep SAS
21.10. Merck KGaA's Life Sciences Company MilliporeSigma Acquired AmpTec
21.11. Sanofi S.A. Acquired Kymab Ltd
21.12. BioNTech SE Acquired GMP Certified Manufacturing Site of Novartis AG
21.13. GlaxoSmithKline plc Acquired 10% Stake In CureVac For $163.67 million
21.14. Merck & Co., Inc. Acquired Themis Bioscience GmbH
21.15. Novavax, Inc. Acquired Praha Vaccines For $167 million
21.16. Bavarian Nordic A/S Acquired Global Rights for Two Vaccines from GSK For $940.07 Million
21.17. Bharat Biotech International Limited Acquired Chiron Behring Vaccines from GlaxoSmithKline

22. Global Vaccines Market Opportunities And Strategies

22.1. Global Vaccines Market In 2026 - Countries Offering Most New Opportunities
22.2. Global Vaccines Market In 2026 - Segments Offering Most New Opportunities
22.3. Global Vaccines Market In 2026 - Growth Strategies
- 22.3.1. Market Trend Based Strategies
- 22.3.2. Competitor Strategies

23. Vaccines Market, Conclusions And Recommendations

23.1. Conclusions
23.2.Recommendations
- 23.2.1.Product
- 23.2.2.Place
- 23.2.3.Price
- 23.2.4.Promotion
- 23.2.5.People

24.Appendix

24.1.Market Data Sources
24.2.Research Methodology
24.3.Currencies
24.4.The Business Research Company
24.5.Copyright and Disclaimer